Wafik S. El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared a post on LinkedIn:
“Dr. David Spetzler, MS, MBA, PhD, President at Caris Life Sciences speaks about ‘Multi-Modal Models to predict recurrence risk in early-stage breast cancer and guide long-term treatment decisions’ at the Inaugural National Caris Precision Oncology Alliance Member Meeting at Brown University Caris Life Sciences.
Dr. Liang Cheng opens session on Therapeutic Biomarkers at the Inaugural National Caris Precision Oncology Alliance Member Meeting at Brown University Caris Life Sciences.
Dr. Hina Khan, MD speaks about ‘KRASmt NSCLC’ at the Inaugural National Caris Precision Oncology Alliance Member Meeting at Brown University Caris Life Sciences
Dr. Khan spoke about unpublished studies looking into the question of
‘How do KRAS comutations impact treatment outcomes and prognosis?’
These are among the genes studied: STK-11, KEAP1, SMARCA4, TP53.
Look for more information from Dr. Khan in upcoming meetings and publications.
Dr. Matthew Hadfield, DO speaks about ‘Biomarkers Predicting IC Response and Toxicity: Are We Getting Close to Primetime?’ at the Inaugural National Caris Precision Oncology Alliance Member Meeting at Brown University Caris Life Sciences.
Dr. Galina Lagos, MD speaks about ‘Targeting MTAP Deletion in Urothelial Carcinomas’ at the at the Inaugural National Caris Precision Oncology Alliance Member Meeting at Brown University Caris Life Sciences.
Dr. Julia Salinaro, MD speaks about ‘Implementation of an institutional gynecologic cancer clinical genomics database’ at the Inaugural National Caris Precision Oncology Alliance Member Meeting at Brown University Caris Life Sciences.
Brown University Graduate Student Makayla Pardo speaks about ‘Deciphering the AML Niche: RNA Sequencing and Spatial Transcriptomics Reveal Diverse Transcriptomic Landscapes in Responders vs. Non-Responders’ at the Inaugural National Caris Precision Oncology Alliance Member Meeting at Brown University Caris Life Sciences.
Dr. lole Ribizzi Akhtar, MD speaks about ‘Head and Neck Cancer Molecular Pathways and Targeted Therapy’ at the Inaugural National Caris Precision Oncology Alliance Member Meeting at Brown University Caris Life Sciences.
Dr. Robert W. Sobol Jr., PhD speaks about ‘Poly (ADP-ribose) binding Proteins in Response to Replication Stress – New Biomarkers and Targets of Resistance’ at the Inaugural National Caris Precision Oncology Alliance Member Meeting at Brown University Caris Life Sciences.
As this work is unpublished, be on the lookout for more information at meetings and the published literature.”
Other articles featuring Wafik S. El-Deiry on OncoDaily.
